Comed was in 1986, when a team of experienced and energetic Pharma professionals decided to go big and to do something different and better than routine. A seed was sown: a beginning was made. These young, dynamic and experienced future leaders chose Baroda (Now called Vadodara), the Educational and Pharma capital of Gujarat (Western India) as their base, a choice which itself proved to be big contributing factor for growth.

SIRO Clinpharm is one of the leading Global Clinical Research Organizations (CROs), offering full scope services conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. We are headquartered in India having global presence in USA, Israel and in Europe at Germany, Czech Republic, Greece, Estonia, Romania, Spain and France.

Intas Pharmaceuticals headquartered at Ahmedabad (India), is now a force to reckon with, in the global pharma horizon. With expertise in a range of formulations, from tablets to injectables to newer drug delivery systems, Intas is currently ranked 18th among the Indian Pharma majors.

Applications are invited from Indian nationals for the posts of Assistant Professors , Associate Professors and Professors in the Departments of Aerospace Engineering, Biological Sciences & Bioengineering, Chemical Engineering, Civil Engineering, Computer Science and Engineering, Electrical Engineering, Industrial and Management Engineering, Materials Science and Engineering, Mechanical Engineering, Chemistry, Mathematics and Statistics, Physics, and Humanities and Social Sciences (HSS).

The DIPSAR is one of the best Pharmacy Institute in India, with a strength of approximately 500 students, situated on a beautiful 10 acre campus in South Delhi. The institute is experiencing a fast academic growth and commitment to the challenges of the 21 s ' century.

One Project Assistant Level-II is required to work in the DBT Project (GAP-0079) entitled “Isolation, Identification, Characterization and Bio-activity assay of anti-diabetic Drug leads from few selected Medicinal Plants of North East India : Voyage for Cure of Diabetes”.

The Institute was established by Govt. of India as National College of Physical Education in 17th  August 1957, the centenary year of the War of Independence, and located at Gwalior, where Rani Lakshmibai of Jhansi, a valiant heroine of the war, had laid her life. The Institute was named after her as a tribute to her role in the glorious freedom struggle.

Meyer,an associate of London based multinational Vitabiotics Ltd.,is a rapidly growing Pharma Co. in India. Leading pharmaceutical manufacturer, founded in 1982 .,in technical collaboration with OMEGA-MEYER Ltd Jersey( Br. Isles). H.O. based in THANE

Post: Executive - Quality Assurance

As one of India’s foremost names in healthcare, Moolchand has been setting standards for the past half century. For over five decades we have been providing healthcare services to three generations of Delhites with care and dedication.

Post: Senior Executive/Executive Pharmacist

Fortis Hospitals, Bangalore, Kolkata, Mulund, Kalyan: Imagine a hospital functioning with you as its centre point. Compassion and warmth along with medical care par excellence. Imagine a hospital that understands the difference between being well and well-being. These, and much more, are wishes brought to reality by a revolution called Fortis Healthcare Network.

The Central University of Punjab, Bathinda (Punjab) has been established through the Central Universities Act 2009 which received the assent of the President of India on 20th March 2009. Its territorial jurisdiction extends to the whole State of Punjab. This newly set up Central University of Punjab (CUP) at Bathinda is poised to write new alphabet on the academic horizon of India.

Surya Healthcare is a subsidiary of Surya Pharmaceuticals Limited with widespread domestic and international operations. The force behind Surya Healthcare is its parent company Surya Pharmaceuticals Limited. It is uniquely positioned in the Pharmaceutical trade known for its competencies in API, formulation and contract manufacturing across different therapeutic segments serving both domestic and international clients.

Flamingo Pharmaceuticals Ltd. is a quality driven pharmaceutical company with an experience of over two decades in global markets, exporting to 52 countries and having Rs.200 crores+ turnover. Flamingo has WHO-GMP/UK MHRA certified 100% EOU unit.

About Authors: Shouvik Bhattacharya1, Tapas Kumar Pal2
NSHM College Of Pharmaceutical Technology, West Bengal (NCPT)
1 - Student of B.pharm, 4^th year,
2 - Assistant Professor of NCPT

Reference ID: PHARMATUTOR-ART-1075

Introduction
Recent trends in Pharmaceutical formulation development technology have presented viable dosage alternatives for patients who may have difficulty swallowing tablets or liquids. Traditional tablets and capsules administered with an 8-oz. (One glass) of water may be inconvenient or impractical for some patients. However, some patients, particularly pediatric and geriatric patients, have difficulty swallowing or chewing solid dosage forms. Many pediatric and geriatric patients are unwilling to take these solid preparations due to fear of choking. For example, a very elderly patient may not be able to swallow a daily dose of antidepressant in the form of a Caplet shaped Tablet. An eight-year-old with allergies could use a more convenient dosage form than antihistamine syrup. A schizophrenic patient in the institutional setting can hide a conventional tablet under his or her tongue to avoid their daily dose of an atypical antipsychotic. A middle-aged woman undergoing radiation therapy for breast cancer may be too nauseous to swallow her H2-blocker. Fast-dissolving tablets (FDTs) / Orally disintegrating tablets (ODTs) are a perfect fit for all of these patients. Fast-dissolving drug delivery systems have rapidly gained acceptance as an important new way of administering drugs. There are multiple fast-dissolving OTC and Rx products on the market worldwide, most of which have been launched in the past 3 to 4 years. There have also been significant increases in the number of new chemical entities under development using a fast-dissolving drug delivery technology.